Skip to main content
Clinical Trials/CTRI/2009/091/000667
CTRI/2009/091/000667
Recruiting
Phase 1

Prospective open-labeled clinical study to evaluate the safety and efficacy of R-HSC-001 in patients with Parkinsons Disease.

Reliance Life Science Pvt Ltd0 sites10 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Reliance Life Science Pvt Ltd
Enrollment
10
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Reliance Life Science Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female of between 35 to 75 years of age.
  • 2\. Patients with current diagnosis of PD.
  • 3\. Patients with at least 5 years since the disease.
  • 4\. Patient is able to comply with and understand the required visit schedule and required tests and procedures.

Exclusion Criteria

  • 1\. History of intracranial surgery.
  • 2\. History of malignancy.
  • 3\. Contraindication of MRI.
  • 4\. Significant coagnitive impairement.
  • 5\. Any contraindication to surgery.
  • 6\. Abnormal hematology and biochemistry.
  • 7\. Positive test result of HBsAg, HCV and HIV.
  • 8\. Pregnant and lactating mother.

Outcomes

Primary Outcomes

Not specified

Similar Trials